0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 121-140 of 211 Articles
Special Article | 
Jonas B. Green, MD, MPH, MSHS; Joseph S. Ross, MD, MHS; Cynthia A. Jackevicius, PharmD, MSc; et al.
JAMA Intern Med. 2013;173(3):229-232. doi:10.1001/jamainternmed.2013.1529.

Original Investigation |  FREE
Tara Gomes, MHSc; Donald A. Redelmeier, MD; David N. Juurlink, MD, PhD; et al.
JAMA Intern Med. 2013;173(3):196-201. doi:10.1001/2013.jamainternmed.733.
Includes: Supplemental Content

Editorial | 
Mitchell H. Katz, MD
JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838.

Editor's Correspondence | 
Bruno Michel, PharmD, PhD; Bapiste Quelennec, PharmD; Emmanuel Andres, MD, PhD
JAMA Intern Med. 2013;173(3):246-247. doi:10.1001/jamainternmed.2013.1235.

Editor's Correspondence | 
Mónica Tarapués, MD; Gloria Cereza, MD; Albert Figueras, MD
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.1614.

Editor's Correspondence | 
Beatrice A. Golomb, MD, PhD; Sabrina Koperski, BS
JAMA Intern Med. 2013;173(3):247-248. doi:10.1001/jamainternmed.2013.2113.

Editor's Correspondence | 
Douglas MacKay, ND
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/2013.jamainternmed.1028.

Editor's Correspondence | 
Donald M. Marcus, MD; Arthur P. Grollman, MD
JAMA Intern Med. 2013;173(2):166-167. doi:10.1001/jamainternmed.2013.1747.

Correction |  FREE
JAMA Intern Med. 2013;173(1):14. doi:10.1001/jamainternmed.2013.3143.

Editor's Correspondence | 
Michael Pazianas, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/2013.jamainternmed.753.

Editor's Correspondence | 
Raphael P. H. Meier, MD; Rene Rizzoli, MD; Robin E. Peter, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/jamainternmed.2013.1238.

Original Investigation |  FREE
Douglas D. DeCarolis, PharmD; Joey G. Thorson, PharmD; Megan A. Clairmont, PharmD; et al.
Arch Intern Med. 2012;172(22):1713-1718. doi:10.1001/2013.jamainternmed.369.
Includes: CME

Invited Commentary | 
Tracy Minichiello, MD
Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456.

Original Investigation |  FREE
Li Zhou, MD, PhD; Saverio M. Maviglia, MD, MS; Lisa M. Mahoney, RPh; et al.
Arch Intern Med. 2012;172(22):1721-1728. doi:10.1001/2013.jamainternmed.438.

Invited Commentary | 
Walter H. Ettinger, MD, MBA
Arch Intern Med. 2012;172(22):1728-1729. doi:10.1001/2013.jamainternmed.607.

Original Investigation |  FREE
Debra A. Butt, MD, MSc, CCFP, FCFP; Muhammad Mamdani, PharmD, MPH; Peter C. Austin, PhD; et al.
Arch Intern Med. 2012;172(22):1739-1744. doi:10.1001/2013.jamainternmed.469.
Includes: Supplemental Content

Original Investigation |  FREE
Kishore M. Gadde, MD; Mariko F. Kopping, MS, RD; H. Ryan Wagner, PhD; et al.
Arch Intern Med. 2012;172(20):1557-1564. doi:10.1001/2013.jamainternmed.99.
Includes: Supplemental Content

Original Investigation |  FREE
Sengwee Toh, ScD; Marsha E. Reichman, PhD; Monika Houstoun, PharmD; et al.
Arch Intern Med. 2012;172(20):1582-1589. doi:10.1001/2013.jamainternmed.34.
Includes: CME, Supplemental Content

Invited Commentary | 
Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(20):1546-1547. doi:10.1001/2013.jamainternmed.293.

Review Article |  FREE
András Komócsi, MD, PhD; András Vorobcsuk, MD, PhD; Dániel Kehl, MS; et al.
Arch Intern Med. 2012;172(20):1537-1545. doi:10.1001/archinternmed.2012.4026.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Brief Report  | 
Association of Rivaroxaban Anticoagulation and Spontaneous Vitreous Hemorrhage
Judy H. Jun, BS; John C. Hwang, MD, MBA
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Ophthalmology
Original Investigation  | 
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion:  SCORE Study Report 15
Ahmad A. Aref, MD; Ingrid U. Scott, MD, MPH; Neal L. Oden, PhD; et al.
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity:  Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD